Company Jiangsu Jibeier Pharmaceutical Co., Ltd.

688566

CNE100004041

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Jiangsu Jibeier Pharmaceutical Co., Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Specialty & Advanced Pharmaceuticals

JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-06-13 pm EDT			5-day change	1st Jan Change
24.49 ^CNY	-1.88%		+3.42%	-21.98%

Jun. 05	Jiangsu Jibeier Pharmaceutical Co., Ltd. announced that it has received CNY 198.161716 million in funding from a group of investors	CI
May. 21	Jibeier Pharmaceutical Gets Patents for Two Products	MT

Jiangsu Jibeier Pharmaceutical Co Ltd is a company engaged in the research, development, production and sales of drugs. The Company's products are comprised of tablets, capsules and eye drops. The tablet products include Leucogen tablets, Nitrendipine and Atenolol tablets, Aceclofenac Enteric-coated tablets and Asarone tablets. The Company's products are used to improve white blood cells, treat high blood pressure, eye infections and other diseases.

Number of employees: 1,445

CNY in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 100.0 %	655	100.0 %	861	100.0 %	+31.49%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	655	100.0 %	861	100.0 %	+31.49%

Managers	Title	Age	Since
Zhong yi Geng CEO	Chief Executive Officer	61	01-11-12
Suo Fu Zhao DFI	Director of Finance/CFO	57	17-05-07
Zheng Wang CHM	Chairman	47	01-11-12
Xiu Gen Wu CTO	Chief Tech/Sci/R&D Officer	59	08-06-30
Jin Chen BRD	Director/Board Member	46	20-09-13
Chun Zhang BRD	Director/Board Member	57	01-11-12
La Mei Li BRD	Director/Board Member	51	01-11-12
Xin Jun Yu BRD	Director/Board Member	63	01-11-12
Xiang Dong Cheng IRC	Investor Relations Contact	33	20-04-30
Zhao Guang Li PRN	Corporate Officer/Principal	43	15-11-30

Members of the board	Title	Age	Since
Guo Xiang Yang BRD	Director/Board Member	72	18-05-09
Zhu Yun Xie BRD	Director/Board Member	49	18-05-09
Zhong yi Geng CEO	Chief Executive Officer	61	01-11-12
Xin Jun Yu BRD	Director/Board Member	63	01-11-12
Tao Hu BRD	Director/Board Member	47	13-02-28
Di He BRD	Director/Board Member	56	18-05-09
Zheng Wang CHM	Chairman	47	01-11-12
La Mei Li BRD	Director/Board Member	51	01-11-12
Chun Zhang BRD	Director/Board Member	57	01-11-12
Jin Chen BRD	Director/Board Member	46	20-09-13

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	189,083,976	45,486,026 ( 24.06 %)	0	24.06 %

Name	Equities	%	Valuation
Zhenjiang Zhongtian Investment Consulting Co. Ltd. 32.29 %	54,400,000	32.29 %	189 M ¥
Zhong yi Geng 30.75 %	51,806,200	30.75 %	180 M ¥
Zhong Ou Asset Management Co., Ltd 2.185 %	3,682,177	2.185 %	13 M ¥
Everbright PGIM Fund Management Co. Ltd. 0.8900 %	1,499,528	0.8900 %	5 M ¥
Da Cheng Fund Management Co., Ltd. 0.7960 %	1,341,138	0.7960 %	5 M ¥
Cinda Fund Management Co. Ltd. 0.6011 %	1,012,777	0.6011 %	4 M ¥
GF Fund Management Co., Ltd. 0.4987 %	840,227	0.4987 %	3 M ¥
China Fund Management Co., Ltd. 0.4250 %	716,140	0.4250 %	2 M ¥
AXA-SPDB Investment Managers Co., Ltd. 0.2265 %	381,548	0.2265 %	1 M ¥
Huatai Securities (Shanghai) Asset Management Co., Ltd. 0.1880 %	316,728	0.1880 %	1 M ¥

Jiangsu Jibeier Pharmaceutical Co. Ltd.

High-Tech Industrial Dev Park

212000, Zhenjiang

http://www.jbepharm.com

address Jiangsu Jibeier Pharmaceutical Co., Ltd.(688566)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

24.49

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.	-21.98%	651M
MERCK KGAA	+19.36%	80.64B
KYOWA KIRIN CO. LTD.	+15.93%	9.07B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+42.06%	4.68B
SK BIOPHARMACEUTICALS CO., LTD.	-22.01%	4.53B
YUHAN CORPORATION	+8.28%	4.06B
BETTA PHARMACEUTICALS CO., LTD.	-26.61%	2.21B
INDIVIOR PLC	+11.22%	2.19B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+11.64%	2B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-42.69%	1.82B

Specialty & Advanced Pharmaceuticals